Key Drivers
- Cash Conversion
- Liquidity Improvement
- Intangible Asset Risk
AIAI Summary
ADUS now looks like a resilient cash-generating operator rather than a clear re-rating story: strong FCF, lower debt, and stable margins support the business, but slowing growth and reimbursement/labor sensitivity mean the stock likely stays capped unless execution re-accelerates enough to justify its premium multiple.
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •Cash Conversion
- •Liquidity Improvement
- •Intangible Asset Risk
ADUS shows steady profitability and strong cash generation with improving liquidity and leverage, but heavy intangible assets and only moderate valuation temper the investment case.
Price Behavior
Key Price Behavior Insights:
- •Trend flip
- •Support test
- •Overhead resistance
ADUS has lost short-term momentum after a sharp early-May pullback and is testing support near $91.6–$91.7, but it remains cautious until price reclaims the $94–$95 resistance band.
Roughly 9% drop from the
Sentiment & News
Key News Insights:
- •EPS Beat
- •Revenue Growth
- •EBITDA Up
Addus HomeCare posted a strong Q1 2026 beat with higher revenue, earnings, and EBITDA, while ongoing investor calls and valuation comparisons kept the stock firmly in focus.
The better-than-expected quarter should support near-term investor sentiment and reinforce ADUS's growth and execution story
Similar Companies in Healthcare
Other companies in the same sector with AI ratings